Thiol-activated DNA damage by α-bromo-2-cyclopentenone.
Some biologically active chemicals are relatively stable in the extracellular environment but, upon entering the cell, undergo biotransformation into reactive intermediates that covalently modify DNA. The diverse chemical reactions involved in the bioactivation of DNA-damaging agents are both fundamentally interesting and of practical importance in medicinal chemistry and toxicology. The work described here examines the bioactivation of α-haloacrolyl-containing molecules. The α-haloacrolyl moiety is found in a variety of cytotoxic natural products including clionastatin B, bromovulone III, discorahabdins A, B, and C, and trichodenone C, in mutagens such as 2-bromoacrolein and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), and in the anticancer drug candidates brostallicin and PNU-151807. Using α-bromo-2-cyclopentenone (1) as a model compound, the activation of α-haloacrolyl-containing molecules by biological thiols was explored. The results indicate that both low molecular weight and peptide thiols readily undergo conjugate addition to 1. The resulting products are consistent with a mechanism in which initial addition of thiols to 1 is followed by intramolecular displacement of bromide to yield a DNA-alkylating episulfonium ion intermediate. The reaction of thiol-activated 1 with DNA produces labile lesions at deoxyguanosine residues. The sequence specificity and salt dependence of this process is consistent with involvement of an episulfonium ion intermediate. The alkylated guanine residue resulting from the thiol-triggered reaction of 1 with duplex DNA was characterized using mass spectrometry. The results provide new insight regarding the mechanisms by which thiols can bioactivate small molecules and offer a more complete understanding of the molecular mechanisms underlying the biological activity of cytotoxic, mutagenic, and medicinal compounds containing the α-haloacrolyl group.
Department of Chemistry, University of Missouri, 125 Chemistry Building Columbia, Missouri 65211, United States.
Mostafa I
MI
Fekry
Nathan E
NE
Price
Hong
H
Zang
Chaofeng
C
Huang
Michael
M
Harmata
Paul
P
Brown
J Scott
JS
Daniels
Kent S
KS
Gates
D000477:Alkylating Agents / Q000633:toxicity*; D000478:Alkylation; D017605:Bromine Compounds / Q000633:toxicity*; D002460:Cell Line; D003517:Cyclopentanes / Q000633:toxicity*; D003545:Cysteine / Q000378:metabolism; D004249:DNA Damage; D005978:Glutathione / Q000378:metabolism; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008623:Mercaptoethanol / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D000477:Alkylating Agents; D017605:Bromine Compounds; D003517:Cyclopentanes; D010455:Peptides; D013438:Sulfhydryl Compounds; D008623:Mercaptoethanol; D005978:Glutathione; D003545:Cysteine; C013905:cyclopentenone
Chem Res Toxicol. 1997 Oct;10(10):1180-5
9348441
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3921-4
16005218
J Nat Prod. 2004 Apr;67(4):542-6
15104481
Annu Rev Microbiol. 2001;55:333-56
11544359
Mutat Res. 1990 Jul;231(1):11-30
2195323
Mutat Res. 1994 Oct;322(4):321-8
7523926
Chem Res Toxicol. 1988 May-Jun;1(3):146-7
2979724
Chem Res Toxicol. 1997 Jan;10(1):2-18
9074797
Org Lett. 2004 May 13;6(10):1633-5
15128254
Drug Metab Dispos. 2002 Aug;30(8):875-82
12124304
J Med Chem. 2006 Apr 20;49(8):2593-9
16610802
Biochemistry. 2009 Oct 13;48(40):9347-59
19757831
J Am Chem Soc. 2001 Mar 7;123(9):2060-1
11456831
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4412-6
1584774
Biochemistry. 1996 Feb 13;35(6):1768-74
8639657
Biochemistry. 1990 Mar 27;29(12):2985-91
2337578
J Nat Prod. 2004 Aug;67(8):1268-76
15332840
Cancer Metastasis Rev. 1993 Jun;12(2):165-76
8375019
Chem Res Toxicol. 1995 Sep;8(6):841-6
7492733
Chem Res Toxicol. 1990 Nov-Dec;3(6):574-9
2103329
Chem Res Toxicol. 1997 Feb;10(2):205-10
9049432
Nucleic Acids Res. 1996 May 1;24(9):1742-6
8649994
Bioorg Med Chem Lett. 2001 Jun 18;11(12):1511-5
11412971
Chem Biol. 1995 Sep;2(9):575-9
9383461
Chem Res Toxicol. 2006 Nov;19(11):1402-14
17112226
Chem Res Toxicol. 2004 Jul;17(7):839-56
15257608
Chem Res Toxicol. 2009 Nov;22(11):1747-60
19757819
Org Lett. 2001 Sep 6;3(18):2789-92
11529757
Chem Res Toxicol. 2003 Dec;16(12):1539-46
14680367
Biochemistry. 1990 Nov 13;29(45):10342-50
2261477
Carcinogenesis. 2000 Mar;21(3):345-51
10688854
Methods Enzymol. 1980;65(1):499-560
6246368
Nucleic Acids Res. 1986 Apr 11;14(7):2971-87
3960738
J Org Chem. 2001 Jul 27;66(15):5232-6
11463277
J Nat Prod. 2005 Feb;68(2):293-308
15730267
Chem Res Toxicol. 1994 Mar-Apr;7(2):199-204
8199309
Chem Res Toxicol. 1995 Apr-May;8(3):465-72
7578934
Bioorg Med Chem Lett. 2005 Apr 15;15(8):2111-3
15808479
Org Lett. 2006 May 25;8(11):2433-6
16706544
J Med Chem. 2004 May 6;47(10):2611-23
15115402
J Antibiot (Tokyo). 1998 Jan;51(1):33-40
9531985
Annu Rev Biochem. 1983;52:711-60
6137189
Nucleic Acids Res. 1994 Sep 25;22(19):3880-6
7937107
Chem Res Toxicol. 2000 Oct;13(10):953-6
11080040
Bioorg Med Chem. 2001 Sep;9(9):2395-401
11553481
Chem Res Toxicol. 2008 Apr;21(4):859-68
18370411
Q Rev Biophys. 1981 Aug;14(3):289-380
7027300
J Med Chem. 1999 Mar 11;42(5):788-90
10072677
Biochim Biophys Acta. 1986 Oct 16;868(1):71-6
3756170
Chem Res Toxicol. 1993 May-Jun;6(3):313-6
8318653
Cancer Res. 1989 Nov 15;49(22):6174-9
2478281
Chem Res Toxicol. 2010 Jan;23(1):99-107
20017514
Chem Res Toxicol. 2004 Jul;17(7):972-82
15257623
Chem Res Toxicol. 2004 Jul;17(7):942-9
15257620
Chem Res Toxicol. 1993 May-Jun;6(3):261-8
8318647
Mutat Res. 1994 Dec;318(3):205-26
7527485
Bioconjug Chem. 1997 May-Jun;8(3):354-64
9177841
Chem Rev. 2002 Jul;102(7):2477-95
12105933
J Am Chem Soc. 2004 Sep 8;126(35):11058-66
15339192
Mutat Res. 1996 Aug 17;355(1-2):13-40
8781575
Bioorg Med Chem Lett. 2003 Apr 7;13(7):1349-52
12657280
Biochemistry. 1982 Feb 2;21(3):419-28
7066293
Bioorg Med Chem Lett. 1998 Mar 3;8(5):535-8
9871613
Cancer Res. 2002 Apr 15;62(8):2332-6
11956092
Z Naturforsch C J Biosci. 1993 Nov-Dec;48(11-12):939-45
8297426